Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Overcoming the barriers of the P53 dysfunction to cure blood cancers

Dr Guillermina Lozano - MD Anderson Cancer Center, Houston, USA
Overcoming the barriers of the P53 dysfunction to cure blood cancers ( Dr Guillermina Lozano - MD Anderson Cancer Center, Houston, USA )
6 Dec 2015

Exciting new immunosuppressive therapy treatment for aplastic anaemia

Dr Danielle Townsley - George Washington University School of Medicine, Washington, USA
Exciting new immunosuppressive therapy treatment for aplastic anaemia ( Dr Danielle Townsley - George Washington University School of Medicine, Washington, USA )
6 Dec 2015

Promising new strategy for treating children with acute lymphocytic leukaemia

Dr Elizabeth Raetz - University of Utah, Salt Lake City, USA
Promising new strategy for treating children with acute lymphocytic leukaemia ( Dr Elizabeth Raetz - University of Utah, Salt Lake City, USA )
5 Dec 2015

Comment: Classification system based on cytogenetics and treatment response identifies leukaemia patients with high-risk clinical features

Dr Wendy Stock - University of Chicago, Chicago, USA
Comment: Classification system based on cytogenetics and treatment response identifies leukaemia patients with high-risk clinical features ( Dr Wendy Stock - University of Chicago, Chicago, USA )
5 Dec 2015

Engineered cells to target multiple myeloma

Dr James Kochenderfer - National Cancer Institute, Bethesda, USA
Engineered cells to target multiple myeloma ( Dr James Kochenderfer - National Cancer Institute, Bethesda, USA )
5 Dec 2015

Classification system based on cytogenetics and treatment response identifies leukaemia patients with high risk clinical features with outstanding outcomes

Dr Elizabeth Raetz - University of Utah, Salt Lake City, USA
Classification system based on cytogenetics and treatment response identifies leukaemia patients with high risk clinical features with outstanding outcomes ( Dr Elizabeth Raetz - University of Utah, Salt Lake City, USA )
5 Dec 2015

Cancer Core Europe: where did it come from and what is its future?

Prof Julio Celis - Danish Cancer Society Research Center, Copenhagen, Denmark
Cancer Core Europe: where did it come from and what is its future? ( Prof Julio Celis - Danish Cancer Society Research Center, Copenhagen, Denmark )
4 Dec 2015

Highlights of the EurocanPlatform Project

Highlights of the EurocanPlatform Project (  )
2 Dec 2015

NCRI 2015 highlights

Prof Charles Swanton - Cancer Research UK's London Research Institute, London, UK
NCRI 2015 highlights ( Prof Charles Swanton - Cancer Research UK's London Research Institute, London, UK )
13 Nov 2015

HVEM expression in melanoma metastasis: prognosis correlation

Prof Daniel Olive - Marseilles Cancer Research Center, Marseilles, France
HVEM expression in melanoma metastasis: prognosis correlation ( Prof Daniel Olive - Marseilles Cancer Research Center, Marseilles, France )
30 Oct 2015

Stereotactic radiation therapy for oligmetastases

Dr David Palma – London Health Sciences Centre, London, Canada
Stereotactic radiation therapy for oligmetastases ( Dr David Palma – London Health Sciences Centre, London, Canada )
23 Oct 2015

What is the potential for using monoclonal antibodies in multiple myeloma?

Prof Sagar Lonial, Prof Pieter Sonneveld, Prof Jesús San Miguel
What is the potential for using monoclonal antibodies in multiple myeloma? ( Prof Sagar Lonial, Prof Pieter Sonneveld, Prof Jesús San Miguel )
6 Oct 2015